株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

組織診断の世界市場の予測 〜2020年:免疫組織化学・In situハイブリダイゼーション・デジタルパソロジー&ワークフロー・特殊染色

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 299359
出版日 ページ情報 英文 176 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
組織診断の世界市場の予測 〜2020年:免疫組織化学・In situハイブリダイゼーション・デジタルパソロジー&ワークフロー・特殊染色 Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020
出版日: 2015年12月02日 ページ情報: 英文 176 Pages
概要

世界の組織診断の市場は2015年から2020年にかけて6.9%のCAGRで推移し、2015年の32億250万米ドルから、2020年には44億7110万米ドルの規模に成長すると予測されています。癌の有病率の拡大や高齢者人口の増加、医療費の拡大などが同市場の主な成長推進因子となっています。一方で、整理統合の進行、厳しい法規制要件、予算の不足などが市場成長を妨げる要因となっています。

当レポートでは、世界の組織診断の市場について調査し、市場概要、市場成長推進因子・阻害因子および市場機会の分析、製品・疾患・技術の各種区分・エンドユーザー・地域/主要国別の主要動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
    • 疾患別
    • エンドユーザー別
    • 製品別
    • 技術別
  • 市場力学
    • 成長推進因子
    • 成長阻害因子
    • 市場機会
    • 市場動向

第6章 市場分析:製品別

  • イントロダクション
  • 消耗品
    • 抗体
    • キット
    • 試薬
    • プローブ
  • 機器
    • スライド染色システム
    • スキャナー
    • 組織作製システム
    • その他

第7章 市場分析:疾患別

  • イントロダクション
  • 乳癌
  • 胃癌
  • リンパ腫
  • 前立腺癌
  • 肺非小細胞癌
  • その他

第8章 市場分析:技術別

  • イントロダクション
  • 免疫組織化学 (IHC)
  • in situ ハイブリダイゼーション (ISH)
  • デジタルパソロジー&ワークフロー管理
  • 特別染色

第9章 市場分析:エンドユーザー別

  • イントロダクション
  • 病院
  • 研究機関
  • 製薬会社
  • CRO
  • その他

第10章 地域分析

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
  • アジア
  • その他の地域

第11章 競合環境

  • イントロダクション
  • 戦略的概要
  • 主要企業
  • 競合状況・動向
    • 新製品の投入・製品のアップグレード
    • 買収
    • 拡張
    • 合意・協力・契約・マーケティングイニシアチブ・提携
    • その他

第12章 企業プロファイル

  • イントロダクション
  • ABBOTT LABORATORIES, INC.
  • AGILENT TECHNOLOGIES, INC.
  • BIO SB
  • BIOGENEX LABORATORIES
  • CELL SIGNALING TECHNOLOGY, INC.
  • DANAHER CORPORATION
  • F. HOFFMAN-LA ROCHE AG
  • サクラファインテックジャパン
  • SIGMA-ALDRICH CORPORATION
  • THERMO FISHER SCIENTIFIC
    • 財務動向
    • 製品・サービス
    • 戦略
    • 発展動向、など

第13章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 2349

The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product segment is further subsegmented into slide-staining systems, scanners, tissue-processing systems, and other instruments. Other instruments include digital pathology systems and histology equipment like automated cover slippers, microtomes, paraffin dispensers, and slide labelers. Consumables product segment is further subsegmented into antibodies, kits, reagents, and probes.

On the basis of technology, the tissue diagnostics market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. On the basis of diseases, the tissue diagnostics market is segmented into breast cancer, gastric cancer, lymphoma, prostate cancer, NSCLC, and other diseases. On the basis of end user, the tissue diagnostics market is segmented into hospitals, pharmaceutical companies, research laboratories, contract research organizations, and other end users.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global tissue diagnostics market in 2015. Asia, on the other hand, is expected to register faster growth during 2015 to 2020.

The key drivers for this market are the increasing prevalence of cancer, growing geriatric population, and growing healthcare expenditure. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global tissue diagnostics market and its subsegments. Secondary information was used to identify the overall revenues, geographic reach, and product portfolios of market players. Estimates of their tissue diagnostics product segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights about key market shares, growth rates, and market drivers for all important subsegments. It maps the market sizes and growth rates of each subsegment and identifies the segments expected to see rapid growth in each geographic segment. The report also includes company profiles of market leaders. These company profiles include financial performances, product portfolios, and market developments for each company. The report also provides a competitive landscape of the tissue diagnostics market. The competitive landscape covers the growth strategies adopted by industry players over the last four years. It also includes an analysis of industry developments.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:

  • Product Development: Product portfolios of the top players in the tissue diagnostics market.
  • Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the tissue diagnostics market.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various tissue diagnostics products across geographies.

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. MARKET SHARE ESTIMATION
    • 2.3.1. KEY DATA FROM SECONDARY SOURCES
    • 2.3.2. KEY DATA FROM PRIMARY SOURCES
    • 2.3.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL TISSUES DIAGNOSTICS MARKET OVERVIEW
  • 4.2. LIFE CYCLE ANALYSIS, BY REGION

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
    • 5.1.1. BY DISEASE
    • 5.1.2. BY END USER
    • 5.1.3. BY PRODUCT
    • 5.1.4. BY TECHNOLOGY
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising incidences of cancer
      • 5.2.1.2. Rapidly increasing aging population
      • 5.2.1.3. Growing healthcare expenditure
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent regulatory requirements and compliance
      • 5.2.2.2. High degree of consolidation
      • 5.2.2.3. Budget constraints
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. High growth in emerging markets
      • 5.2.3.2. Increased use of personalized medicine
    • 5.2.4. TREND
      • 5.2.4.1. Increasing number of reagent rental agreements

6. TISSUE DIAGNOSTICS MARKET, BY PRODUCT 45

  • 6.1. INTRODUCTION
  • 6.2. CONSUMABLES
    • 6.2.1. ANTIBODIES
    • 6.2.2. KITS
    • 6.2.3. REAGENTS
    • 6.2.4. PROBES
  • 6.3. INSTRUMENTS
    • 6.3.1. SLIDE-STAINING SYSTEMS
    • 6.3.2. SCANNERS
    • 6.3.3. TISSUE-PROCESSING SYSTEMS
    • 6.3.4. OTHER INSTRUMENTS

7. TISSUE DIAGNOSTICS MARKET, BY DISEASES

  • 7.1. INTRODUCTION
  • 7.2. BREAST CANCER
  • 7.3. GASTRIC CANCER
  • 7.4. LYMPHOMA
  • 7.5. PROSTATE CANCER
  • 7.6. NON-SMALL CELL LUNG CANCER
  • 7.7. OTHER DISEASES

8. TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 8.1. INTRODUCTION
  • 8.2. IMMUNOHISTOCHEMISTRY (IHC)
  • 8.3. IN SITU HYBRIDIZATION (ISH)
  • 8.4. DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT
  • 8.5. SPECIAL STAINING

9. TISSUE DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITALS
  • 9.3. RESEARCH LABORATORIES
  • 9.4. PHARMACEUTICAL COMPANIES
  • 9.5. CONTRACT RESEARCH ORGANIZATIONS
  • 9.6. OTHER END USERS

10. TISSUE DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
  • 10.4. ASIA
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. INTRODUCTION
  • 11.2. STRATEGIC OVERVIEW
  • 11.3. LEADING PLAYERS IN THE TISSUE DIAGNOSTICS MARKET
  • 11.4. COMPETITIVE SITUATION AND TRENDS
    • 11.4.1. NEW PRODUCTS LAUNCHES AND PRODUCT UPGRADES
    • 11.4.2. ACQUISITIONS
    • 11.4.3. EXPANSIONS
    • 11.4.4. AGREEMENTS, COLLABORATIONS, CONTRACTS, MARKETING INITIATIVES, AND PARTNERSHIPS
    • 11.4.5. OTHER DEVELOPMENTS

12. COMPANY PROFILES

  • 12.1. INTRODUCTION
  • 12.2. ABBOTT LABORATORIES, INC.
  • 12.3. AGILENT TECHNOLOGIES, INC.
  • 12.4. BIO SB
  • 12.5. BIOGENEX LABORATORIES
  • 12.6. CELL SIGNALING TECHNOLOGY, INC.
  • 12.7. DANAHER CORPORATION
  • 12.8. F. HOFFMAN-LA ROCHE AG
  • 12.9. SAKURA FINETEK JAPAN CO., LTD.
  • 12.10. SIGMA-ALDRICH CORPORATION
  • 12.11. THERMO FISHER SCIENTIFIC

*Details On Financials, Products & Services, Key Strategy, & Recent Developments Might Not Be Captured In Case Of Unlisted Companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: TISSUE DIAGNOSTICS MARKET SUMMARY
  • TABLE 2: RISING INCIDENCES OF CANCER ARE THE PRIMARY DRIVER FOR THE TISSUE DIAGNOSTICS MARKET
  • TABLE 3: STRINGENT REGULATORY REQUIREMENTS IS A KEY RESTRAINT FOR THE GROWTH OF THE TISSUE DIAGNOSTICS MARKET
  • TABLE 4: EMERGING ECONOMIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES
  • TABLE 5: INCREASING NUMBER OF REAGENT RENTAL AGREEMENTS IS A MAJOR TREND FOR THE GROWTH OF THIS MARKET
  • TABLE 6: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 7: TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2013-2020 (USD MILLION)
  • TABLE 8: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 9: TISSUE DIAGNOSTICS MARKET SIZE FOR ANTIBODIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 10: TISSUE DIAGNOSTICS MARKET SIZE FOR KITS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 11: TISSUE DIAGNOSTICS MARKET SIZE FOR REAGENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 12: TISSUE DIAGNOSTICS MARKET SIZE FOR PROBES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 13: TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENT, 2013-2020 (USD MILLION)
  • TABLE 14: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 15: TISSUE DIAGNOSTICS MARKET SIZE FOR SLIDE-STAINING SYSTEMS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 16: TISSUE DIAGNOSTICS MARKET SIZE FOR SCANNERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 17: TISSUE DIAGNOSTICS MARKET SIZE FOR TISSUE-PROCESSING SYSTEMS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 18: TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER INSTRUMENTS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 19: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 20: TISSUE DIAGNOSTICS MARKET SIZE FOR BREAST CANCER, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 21: TISSUE DIAGNOSTICS MARKET SIZE FOR GASTRIC CANCER, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 22: TISSUE DIAGNOSTICS MARKET SIZE FOR LYMPHOMA, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 23: TISSUE DIAGNOSTICS MARKET SIZE FOR PROSTATE CANCER, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 24: TISSUE DIAGNOSTICS MARKET SIZE FOR NON-SMALL CELL LUNG CANCER, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 25: TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER DISEASES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 26: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 27: TISSUE DIAGNOSTICS MARKET SIZE FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 28: TISSUE DIAGNOSTICS MARKET SIZE FOR IN SITU HYBRIDIZATION, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 29: TISSUE DIAGNOSTICS MARKET SIZE FOR DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 30: TISSUE DIAGNOSTICS MARKET SIZE FOR SPECIAL STAINING, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 31: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 32: TISSUE DIAGNOSTICS MARKET SIZE FOR HOSPITALS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 33: TISSUE DIAGNOSTICS MARKET SIZE FOR RESEARCH LABORATORIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 34: TISSUE DIAGNOSTICS MARKET SIZE FOR PHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 35: TISSUE DIAGNOSTICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 36: TISSUE DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 37: TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION)
  • TABLE 38: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • TABLE 39: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 40: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 41: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 42: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 43: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 44: NORTH AMERICA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 45: U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 46: U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 47: U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 48: U.S.: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 49: CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 50: CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 51: CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 52: CANADA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 53: EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 54: EUROPE: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 55: EUROPE: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 56: EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 57: EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 58: EUROPE: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 59: ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 60: ASIA: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 61: ASIA: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 62: ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 63: ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 64: ASIA: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 65: ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION)
  • TABLE 66: ROW: TISSUE DIAGNOSTICS MARKET SIZE FOR CONSUMABLES, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 67: ROW: TISSUE DIAGNOSTICS MARKET SIZE FOR INSTRUMENTS, BY TYPE, 2013-2020 (USD MILLION)
  • TABLE 68: ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2013-2020 (USD MILLION)
  • TABLE 69: ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION)
  • TABLE 70: ROW: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2013-2020 (USD MILLION)
  • TABLE 71: MARKET DEVELOPMENTS BETWEEN 2012 AND 2015
  • TABLE 72: NEW PRODUCT LAUNCHES AND PRODUCT UPGRADES, 2012-2015
  • TABLE 73: ACQUISITIONS, 2012-2015
  • TABLE 74: EXPANSIONS, 2012-2015
  • TABLE 75: AGREEMENTS, COLLABORATIONS, CONTRACTS, MARKETING INITIATIVES, AND PARTNERSHIPS, 2012-2015
  • TABLE 76: OTHER DEVELOPMENTS, 2012-2015

LIST OF FIGURES

  • FIGURE 1: GLOBAL TISSUE DIAGNOSTICS MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2015 VS. 2020 (USD MILLION)
  • FIGURE 8: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 (USD MILLION)
  • FIGURE 9: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2015 VS. 2020 (USD MILLION)
  • FIGURE 10: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2015 VS. 2020 (USD MILLION)
  • FIGURE 11: TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2015 VS. 2020 (USD MILLION)
  • FIGURE 12: RISING INCIDENCES OF CANCER TO DRIVE MARKET GROWTH
  • FIGURE 13: IMMUNOHISTOCHEMISTRY SEGMENT TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2015
  • FIGURE 14: ASIA TO WITNESS HIGHEST GROWTH RATE IN THE FORECAST PERIOD (2015 TO 2020)
  • FIGURE 15: ASIA HOLDS LUCRATIVE GROWTH OPPORTUNITIES
  • FIGURE 16: TISSUE DIAGNOSTICS MARKET, BY DISEASE
  • FIGURE 17: TISSUE DIAGNOSTICS MARKET, BY END USER
  • FIGURE 18: TISSUE DIAGNOSTICS MARKET, BY PRODUCT
  • FIGURE 19: TISSUE DIAGNOSTICS MARKET, BY TECHNOLOGY
  • FIGURE 20: INCREASING INCIDENCES OF CANCER ARE EXPECTED TO DRIVE THE TISSUE DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 21: INCREASING HEALTHCARE EXPENDITURE WILL DRIVE THE TISSUE DIAGNOSTICS MARKET
  • FIGURE 22: RAPID GROWTH IN HEALTHCARE EXPENDITURE IN EMERGING MARKETS IS AN IMPORTANT GROWTH OPPORTUNITY
  • FIGURE 23: TISSUE DIAGNOSTICS MARKET, BY PRODUCT
  • FIGURE 24: TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2015 (USD MILLION)
  • FIGURE 25: TISSUE DIAGNOSTICS MARKET SIZE, BY CONSUMABLES, 2015 (USD MILLION)
  • FIGURE 26: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE CONSUMABLES PRODUCT SEGMENT IN 2015
  • FIGURE 27: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE ANTIBODIES PRODUCT SEGMENT IN 2015
  • FIGURE 28: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE KITS PRODUCT SEGMENT IN 2015
  • FIGURE 29: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE REAGENTS PRODUCT SEGMENT IN 2015
  • FIGURE 30: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROBES PRODUCT SEGMENT IN 2015
  • FIGURE 31: TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENT, 2015 (USD MILLION)
  • FIGURE 32: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE INSTRUMENTS PRODUCT SEGMENT IN 2015
  • FIGURE 33: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SLIDE-STAINING SYSTEMS PRODUCT SEGMENT IN 2015
  • FIGURE 34: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE SCANNERS PRODUCT SEGMENT IN 2015
  • FIGURE 35: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE TISSUE-PROCESSING SYSTEMS PRODUCT SEGMENT IN 2015
  • FIGURE 36: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE OTHER INSTRUMENTS PRODUCT SEGMENT IN 2015
  • FIGURE 37: TISSUE DIAGNOSTICS MARKET, BY DISEASE
  • FIGURE 38: TISSUE DIAGNOSTICS MARKET SIZE, BY DISEASE, 2015 (USD MILLION)
  • FIGURE 39: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE BREAST CANCER DISEASE SEGMENT IN 2015
  • FIGURE 40: ASIA TO BE THE FASTEST-GROWING SEGMENT IN THE TISSUE DIAGNOSTICS MARKET FOR GASTRIC CANCER DURING THE FORECAST PERIOD
  • FIGURE 41: ASIA TO WITNESS HIGHEST GROWTH IN THE LYMPHOMA DISEASE SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 42: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE PROSTATE CANCER DISEASE SEGMENT IN 2015
  • FIGURE 43: NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE NON-SMALL CELL LUNG CANCER DISEASE SEGMENT IN 2015
  • FIGURE 44: ASIA TO BE THE FASTEST-GROWING MARKET IN THE OTHER DISEASES SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 45: TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY TECHNOLOGY
  • FIGURE 46: TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2015 (USD MILLION)
  • FIGURE 47: NORTH AMERICA TO DOMINATE THE IMMUNOHISTOCHEMISTRY TECHNOLOGY SEGMENT IN 2015
  • FIGURE 48: ASIA TO BE THE FASTEST-GROWING MARKET IN THE IN SITU HYBRIDIZATION TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 49: ASIA TO WITNESS HIGHEST GROWTH IN THE DIGITAL PATHOLOGY AND WORKFLOW MANAGEMENT TECHNOLOGY SEGMENT DURING THE FORECAST PERIOD
  • FIGURE 50: NORTH AMERICA TO DOMINATE THE SPECIAL STAINING TECHNOLOGY SEGMENT IN 2015
  • FIGURE 51: TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY END USER
  • FIGURE 52: TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2015 (USD MILLION)
  • FIGURE 53: NORTH AMERICA TO DOMINATE THE HOSPITAL END-USER SEGMENT IN 2015
  • FIGURE 54: THE RESEARCH LABORATORIES END-USER SEGMENT IN ASIA TO WITNESS THE HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 55: PHARMACEUTICAL COMPANIES SEGMENT IN ASIA TO WITNESS HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 56: NORTH AMERICA TO DOMINATE THE CONTRACT RESEARCH ORGANIZATIONS END-USER SEGMENT IN 2015
  • FIGURE 57: NORTH AMERICA TO DOMINATE THE OTHER END-USERS SEGMENT IN 2015
  • FIGURE 58: TISSUE DIAGNOSTICS MARKET SEGMENTATION, BY REGION
  • FIGURE 59: NORTH AMERICA TO DOMINATE THE GLOBAL TISSUE DIAGNOSTICS MARKET IN 2015
  • FIGURE 60: TISSUE DIAGNOSTICS MARKET IN ASIA TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 61: NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 62: U.S. IS EXPECTED TO BE THE FASTEST-GROWING MARKET IN NORTH AMERICA IN 2015
  • FIGURE 63: CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN NORTH AMERICA DURING THE FORECAST PERIOD
  • FIGURE 64: ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN NORTH AMERICA DURING THE FORECAST PERIOD
  • FIGURE 65: SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN NORTH AMERICA DURING THE FORECAST PERIOD
  • FIGURE 66: BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 67: IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 68: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN NORTH AMERICA IN 2015
  • FIGURE 69: CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN EUROPE DURING THE FORECAST PERIOD
  • FIGURE 70: ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN EUROPE DURING THE FORECAST PERIOD
  • FIGURE 71: SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN EUROPE DURING THE FORECAST PERIOD
  • FIGURE 72: BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN EUROPE IN 2015
  • FIGURE 73: IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN EUROPE IN 2015
  • FIGURE 74: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN EUROPE IN 2015
  • FIGURE 75: ASIA: MARKET SNAPSHOT
  • FIGURE 76: CONSUMABLES TO COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN ASIA DURING THE FORECAST PERIOD
  • FIGURE 77: ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN ASIA DURING THE FORECAST PERIOD
  • FIGURE 78: SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN ASIA DURING THE FORECAST PERIOD
  • FIGURE 79: BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN ASIA IN 2015
  • FIGURE 80: IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ASIA IN 2015
  • FIGURE 81: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ASIA IN 2015
  • FIGURE 82: CONSUMABLES COMMAND THE LARGEST SHARE OF THE TISSUE DIAGNOSTICS MARKET IN ROW DURING THE FORECAST PERIOD
  • FIGURE 83: ANTIBODIES TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR CONSUMABLES IN ROW DURING THE FORECAST PERIOD BETWEEN 2015-2020
  • FIGURE 84: SLIDE STAINING SYSTEMS TO DOMINATE THE TISSUE DIAGNOSTICS MARKET FOR INSTRUMENTS IN ROW DURING THE FORECAST PERIOD
  • FIGURE 85: BREAST CANCER TO FORM THE LARGEST DISEASE SEGMENT IN ROW IN 2015
  • FIGURE 86: IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN ROW IN 2015
  • FIGURE 87: HOSPITALS TO FORM THE LARGEST END-USER SEGMENT IN ROW IN 2015
  • FIGURE 88: KEY DEVELOPMENTS IN THE TISSUE DIAGNOSTICS MARKET, 2010-2015
  • FIGURE 89: TISSUE DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
  • FIGURE 90: SNAPSHOT OF THE FINANCIAL PERFORMANCES OF THE LEADING MARKET PLAYERS
  • FIGURE 91: ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 92: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 93: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 94: F. HOFFMAN-LA ROCHE AG: COMPANY SNAPSHOT
  • FIGURE 95: SIGMA-ALDRICH CORPORATION: COMPANY SNAPSHOT
  • FIGURE 96: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
Back to Top